FDA-filed SPL labeling · retrieved through openFDA

Aspirin and Extended-Release Dipyridamole

Aspirin and extended-release dipyridamole is a combination antiplatelet medication used to reduce the risk of stroke in people who have already had a transient ischemic attack (TIA) or ischemic stroke.

Drug classes Nonsteroidal Anti-inflammatory Drug
Rx Forms 2 Route Oral
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 4 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveJan 14, 2026
Clinical labels in scope 4
AvailabilityRx
Earliest approval/marketing year 2016
FDA-listed product records 10
Boxed warningNone found in compared labels
How we combine label and product data →
No current FDA shortage listed · checked Sep 15, 2026
Aspirin and Extended-Release Dipyridamole at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Aspirin and extended-release dipyridamole is a two-ingredient antiplatelet combination prescribed to lower the risk of another stroke in people who have already had a TIA or ischemic stroke. Headache and stomach upset are common at the start of treatment but often improve; if headaches are severe, ask your prescriber about a temporary dosing adjustment. Bleeding is the most serious risk — let your care team know about all other medications you take and seek medical help right away for any signs of unusual or serious bleeding.

📖 Aspirin and Extended-Release Dipyridamole: Patient Information Guide

A plain-language walkthrough of Aspirin and Extended-Release Dipyridamole — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for

Aspirin and extended-release dipyridamole is a combination antiplatelet medication approved for one main purpose across both its capsule forms:

  • Reducing the risk of stroke in people who have already experienced a transient ischemia of the brain (TIA, or "mini-stroke") or a completed ischemic stroke caused by a blood clot (thrombosis).
⚙️How it works

This medication works through two separate but complementary pathways — and that's exactly why the combination is more effective than either ingredient alone. Dipyridamole works by blocking the uptake of adenosine into platelets and by inhibiting an enzyme called phosphodiesterase (PDE); together, these actions raise chemical signals inside platelets that tell them to stay inactive and not clump together. Aspirin permanently disables a different enzyme — cyclooxygenase — inside platelets, stopping them from making thromboxane A2, a chemical that normally triggers platelet clumping and blood vessel narrowing. By targeting two different steps in the clotting process, the combination provides additive protection against the kind of clots that can block blood flow to the brain.

💊How it's taken

Both the capsule and the extended-release capsule forms are taken orally twice a day — one in the morning and one in the evening. Capsules must be swallowed whole (do not chew) and can be taken with or without food. If headaches are intolerable when starting treatment, your prescriber may temporarily adjust the schedule to one capsule at bedtime; the goal is to return to the standard twice-daily routine within about one week as headaches typically ease with continued use.

  • Do not substitute this combination product with separate aspirin tablets and dipyridamole tablets — they are not interchangeable.
  • Always follow your prescriber's specific instructions for your situation.
🤒Side effects — in detail

The most commonly reported side effects — occurring in more than 1 in 10 patients — include:

  • Headache — the most frequent complaint, especially early in treatment
  • Upset stomach or heartburn (dyspepsia)
  • Abdominal pain
  • Nausea
  • Diarrhea
  • Vomiting
  • Dizziness
  • Unusual bleeding (e.g., nosebleeds, easy bruising)

Seek prompt medical attention for signs of serious bleeding — such as black or tarry stools, vomiting blood, or bleeding that won't stop — or for chest pain, sudden severe headache, fainting, or signs of an allergic reaction like facial swelling or difficulty breathing.

⚠️Warnings & precautions
  • Increased bleeding risk: This is the most important safety concern. The risk is higher if you also use blood thinners, other antiplatelet drugs, NSAIDs, or drink heavily. Watch for stomach or intestinal bleeding (black stools, stomach pain) and signs of bleeding in the brain (sudden severe headache, weakness, confusion).
  • Pregnancy: Avoid use in the third trimester — aspirin can cause serious harm to the unborn baby, including low birth weight, bleeding complications, and in rare cases, stillbirth or neonatal death. Talk to your doctor before using this medication if you are pregnant or planning to become pregnant.
  • Children and teenagers: Do not use in children or teens with a viral illness — the aspirin component raises the risk of Reye syndrome, a rare but life-threatening condition affecting the brain and liver.
  • Coronary artery disease: Dipyridamole widens blood vessels and can trigger or worsen chest pain in people with coronary artery disease. Also, the aspirin dose in this product may not be sufficient to protect against heart attack or angina on its own.
  • Low blood pressure: Dipyridamole can lower blood pressure; use with care if you already have hypotension.
  • Severe kidney or liver disease: Avoid this medication in patients with severe kidney failure or significant liver disease.
🔀What it interacts with

This medication interacts with a number of commonly used drugs and substances — always give your prescriber and pharmacist a full list of everything you take:

  • Blood thinners (warfarin, heparin): Aspirin adds to their effect, significantly raising bleeding risk.
  • Other antiplatelet drugs and anagrelide: Combined use increases bleeding risk further.
  • NSAIDs (ibuprofen, naproxen, etc.): Concurrent use may increase bleeding and can reduce kidney function.
  • Adenosine / regadenoson: Dipyridamole raises their blood and cardiovascular effects; dosing adjustment may be needed, especially around stress testing.
  • ACE inhibitors: Aspirin may blunt the blood pressure-lowering effect of these heart medications.
  • Beta blockers and diuretics: Aspirin may reduce the effectiveness of both by affecting kidney prostaglandins.
  • Methotrexate: Aspirin can increase methotrexate levels, raising the risk of serious bone marrow toxicity — especially in older adults or those with kidney problems.
  • Oral diabetes medications: Aspirin may enhance their glucose-lowering effect, potentially causing low blood sugar.
  • Phenytoin / valproic acid (seizure medications): Aspirin can alter blood levels of these drugs.
  • Cholinesterase inhibitors (used in myasthenia gravis or dementia): Dipyridamole may counteract their effect.
  • Alcohol (3+ drinks daily): Increases bleeding risk when combined with aspirin.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it
  • Tell your prescriber about any known allergy to aspirin, NSAIDs, or any ingredient in this product — allergic reactions can be severe, including hives, swelling, or breathing trouble.
  • Do not take this medication if you have asthma, nasal polyps, and chronic nasal inflammation together (a condition called aspirin-exacerbated respiratory disease).
  • Do not give to children or teenagers with a viral illness (such as flu or chickenpox) — risk of Reye syndrome.
  • Avoid during the third trimester of pregnancy; discuss use during earlier trimesters with your doctor, as fetal harm is possible.
  • If breastfeeding, discuss with your doctor — both dipyridamole and aspirin's breakdown product (salicylic acid) pass into breast milk.
  • Avoid if you have severe kidney failure (very low kidney filtration rate); use with caution and discuss with your prescriber if you have any kidney disease.
  • Use with caution if you have liver disease — dipyridamole has been linked to elevated liver enzymes and, in rare cases, liver failure.
  • If you have coronary artery disease or low blood pressure, let your prescriber know — dipyridamole's vessel-widening effect can worsen these conditions.
  • Older adults may have higher dipyridamole levels in their blood; your prescriber should be aware of your age and any other health conditions.
🚑If you take too much

An overdose of this combination is likely to show signs of dipyridamole toxicity first — including flushing, sweating, restlessness, weakness, dizziness, a drop in blood pressure, and a fast heartbeat. Too much aspirin can cause ringing in the ears (tinnitus), fever, and in severe cases, dangerous changes in body chemistry.

If you suspect an overdose, call 911 or contact Poison Control immediately (1-800-222-1222 in the US). Do not wait for symptoms to worsen — prompt medical care is essential.

📡Pharmacodynamics — effects in the body

Both aspirin and dipyridamole work by reducing the ability of platelets (tiny blood cells) to clump together and form clots. Dipyridamole does this by raising the level of chemical messengers inside platelets that keep them inactive, blocking their response to several clot-triggering signals. Aspirin permanently disables a key clotting enzyme in platelets, preventing production of a clot-promoting chemical called thromboxane A2. Together, their antiplatelet effects add up, providing greater clot prevention than either drug alone.

🔬Pharmacokinetics — how your body processes it

After an oral dose, dipyridamole from this combination reaches peak blood levels in about 2 hours on average, and it is almost completely bound to proteins in the bloodstream. It is broken down mainly in the liver and eliminated primarily through bile and stool. Aspirin is absorbed faster — typically within 30–60 minutes — and is converted in the liver and gut to salicylic acid; it and its byproducts are eliminated through the urine. Older adults tend to have higher dipyridamole levels in their blood compared to younger patients. Taking the capsules with a high-fat meal slightly reduces dipyridamole absorption, but this is not considered clinically meaningful.

📦How to store it

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) . Protect from excessive moisture.

📄 Written from Aspirin and Extended-Release Dipyridamole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Aspirin and Extended-Release Dipyridamole — the kind of thing our pharmacy team would talk through with you at the counter.

Why did my doctor prescribe this instead of just regular aspirin?
Great question. After a TIA or ischemic stroke, research has shown that combining aspirin with extended-release dipyridamole reduces the risk of another stroke better than aspirin alone. The two drugs block platelet clotting through different pathways, so together they give you added protection. Your doctor chose this combination specifically for stroke prevention.
I have a really bad headache since starting this medication — is that normal? Should I stop taking it?
Headache is actually the most common side effect with this medication, especially in the first few weeks. The good news is it usually gets better on its own as your body adjusts. Don't stop taking it without talking to your doctor first — stopping raises your stroke risk. If it's truly unbearable, your prescriber may temporarily switch you to one capsule at bedtime only; the plan would be to go back to the full twice-daily dose within about a week.
Can I take ibuprofen or other over-the-counter pain relievers while I'm on this?
You need to be careful. Ibuprofen, naproxen, and other NSAIDs combined with this medication can increase your risk of bleeding and may also put extra strain on your kidneys. Acetaminophen (Tylenol) is generally a safer choice for pain relief, but check with your pharmacist or doctor before taking anything new — even things you can buy without a prescription.
Are there any signs of bleeding I should watch out for?
Yes — and this is important. Because this medication reduces clotting, you can bleed more easily. Watch for stomach pain, black or tarry stools, vomiting blood, or bleeding that won't stop after a cut. More seriously, get emergency help right away if you have a sudden severe headache, weakness on one side, confusion, or trouble speaking — these could be signs of bleeding in the brain. Also let your doctor know if you drink three or more alcoholic drinks a day, since that raises bleeding risk further.
Is it safe to take this if I'm pregnant or trying to get pregnant?
This medication can harm an unborn baby, and it should definitely be avoided in the third trimester of pregnancy. Even earlier in pregnancy, the risks aren't fully understood. If you're pregnant, planning to become pregnant, or think you might be pregnant, tell your doctor right away so they can weigh the risks and benefits and consider your options. Don't stop the medication on your own without guidance, since stroke prevention matters for your health too.
Do I need to swallow the capsule whole, or can I open it or chew it?
You must swallow the capsule whole — do not chew, crush, or open it. The dipyridamole in this medication is designed to release slowly over time (that's what 'extended-release' means), and breaking the capsule would change how the drug is absorbed. You can take it with or without food, whichever is more comfortable for your stomach.
Is Aspirin and Extended-Release Dipyridamole available over the counter?
Aspirin and Extended-Release Dipyridamole is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Aspirin and Extended-Release Dipyridamole first available?
Aspirin and Extended-Release Dipyridamole has been available in the United States since at least 2016, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Aspirin and Extended-Release Dipyridamole?
Aspirin and Extended-Release Dipyridamole is supplied by 4 manufacturers listed in the FDA NDC Directory, including AvKARE, Micro Labs Limited, Amneal Pharmaceuticals LLC.

💬 Answers drafted from Aspirin and Extended-Release Dipyridamole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Aspirin and Extended-Release Dipyridamole comes

Aspirin and Extended-Release Dipyridamole is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Capsule

By mouth
How this form is used
What it may be used for
  • Aspirin and Extended-Release Dipyridamole capsules are used to reduce the risk of stroke in people who have had a TIA or ischemic stroke caused by a blood clot.
Important instructions
  • Aspirin and Extended-Release Dipyridamole capsules are taken by mouth twice daily — one in the morning and one in the evening.
  • Swallow Aspirin and Extended-Release Dipyridamole capsules whole; do not chew.
  • Aspirin and Extended-Release Dipyridamole capsules may be taken with or without food.
  • Aspirin and Extended-Release Dipyridamole capsules are not interchangeable with separate aspirin and dipyridamole tablets.
Available strengths 1 strength
6 FDA-listed product records

Extended-release capsule

By mouth
How this form is used
What it may be used for
  • Aspirin And Extended-release Dipyridamole extended-release capsules are indicated to reduce the risk of stroke in patients who have had a TIA or completed ischemic stroke due to a blood clot.
Important instructions
  • Aspirin And Extended-release Dipyridamole extended-release capsules are taken by mouth twice daily — once in the morning and once in the evening.
  • Swallow Aspirin And Extended-release Dipyridamole extended-release capsules whole; do not chew.
  • Aspirin And Extended-release Dipyridamole extended-release capsules may be taken with or without food.
  • If headaches during early treatment are unbearable, ask your prescriber about temporarily switching to one capsule at bedtime; plan to return to the twice-daily schedule within about one week.
Available strengths 1 strength
4 FDA-listed product records

📊 Aspirin and Extended-Release Dipyridamole across the U.S. market

How Aspirin and Extended-Release Dipyridamole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

2
Dose forms
4
Manufacturers
1
Brand names
10
FDA-listed product records
2016
First marketed

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

AvKARE30%
Micro Labs Limited30%
Amneal Pharmaceuticals LLC30%
Bryant Ranch Prepack10%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Aspirin and Extended-Release Dipyridamole is used

A general measure of how commonly Aspirin and Extended-Release Dipyridamole is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Aspirin and Extended-Release Dipyridamole is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

313
Medicaid prescriptions filled (Q1–Q4 2025)
$16,662 gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Aspirin and Extended-Release Dipyridamole prescribed? Of the 1,594 medications we measure, Aspirin and Extended-Release Dipyridamole ranks #1,416 by Medicaid prescriptions — more than 11% of them.

Where Aspirin and Extended-Release Dipyridamole ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Aspirin and Extended-Release Dipyridamole product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

Other Aspirin and Extended-Release Dipyridamole products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)

313 Medicaid prescriptions (Q1–Q4 2025) 100% of Aspirin and Extended-Release Dipyridamole prescriptions shown $16,662 gross reimbursement (before rebates) ≈ $53 per prescription (gross)

Summed across the 2 of 4 listed NDC products with Medicaid activity.

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Aspirin and Extended-Release Dipyridamole, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 2 of 4 listed Aspirin and Extended-Release Dipyridamole NDCs with Medicaid activity.

🔍 Compare Aspirin and Extended-Release Dipyridamole products

A representative set of FDA-listed product records for Aspirin and Extended-Release Dipyridamole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category Details
💊Capsule
ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg Oral Amneal Pharmaceuticals LLC ANDA View NDC →
25; 200 mg/1; mg Oral Amneal Pharmaceuticals LLC × 2 listings ANDA View NDC →
ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg Oral AvKARE ANDA View NDC →
25; 200 mg/1; mg Oral AvKARE × 2 listings ANDA View NDC →
💊Extended-release capsule
ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg Oral Bryant Ranch Prepack ANDA View NDC →
ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg Oral Micro Labs Limited ANDA View NDC →
25; 200 mg/1; mg Oral Micro Labs Limited × 2 listings ANDA View NDC →

Showing 10 of 10 products — FDA National Drug Code Directory. See every product, package size and price: browse all 10 Aspirin and Extended-Release Dipyridamole NDCs →

🏭 Manufacturers & labelers

AvKARE 3 Micro Labs Limited 3 Amneal Pharmaceuticals LLC 3 Bryant Ranch Prepack 1

RxNorm drug class

Aspirin and Extended-Release Dipyridamole belongs to the Platelet Aggregation Inhibitor class.

Pharmacologic class Platelet Aggregation Inhibitor, Nonsteroidal Anti-inflammatory Drug
Drug family (ATC) Other agents for local oral treatment, Platelet aggregation inhibitors excl. heparin, Salicylic acid and derivatives
How it works Cyclooxygenase Inhibitors

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jan 14, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Aspirin and Extended-Release Dipyridamole.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Aspirin and Extended-Release Dipyridamole after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
4
NDC products indexed
10
Distinct labelers/manufacturers represented
4
Linked representative label
AvKARE
Linked label effective
Jan 14, 2026
Composite sections available
22
Linked SPL Set ID
c9a73ec9-e468-46a5-b2c1-99f1f1536585
Linked SPL Document ID
485b7e08-a8d8-f491-e063-6294a90aa415
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 4 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. AvKARE is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.